- Investing Ideas
- Chinese Pharmaceuticals & Biotech Undervalued based on future growth
Chinese Pharmaceuticals & Biotech Undervalued based on future growth
Results
3
0 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
3 companies
Zhejiang Medicine
Market Cap: CN¥11.5b
Manufactures and sells life nutrition and pharmaceuticals products in China and internationally.
600216
CN¥12.11
7D
4.1%
1Y
-24.0%
Zhejiang Garden BiopharmaceuticalLtd
Market Cap: CN¥6.8b
Zhejiang Garden Biopharmaceutical Co.,Ltd.
300401
CN¥12.42
7D
3.2%
1Y
-21.8%
Hunan Fangsheng Pharmaceutical
Market Cap: CN¥4.2b
Engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China.
603998
CN¥9.46
7D
5.6%
1Y
-18.2%